A recent court decision offers an important lesson for companies considering bringing a trade secret claim: before filing suit, companies should ensure that their confidential information — even if it was stolen by the defendant — is actually a trade secret.
The United States Department of Agriculture and the Food and Drug Administration have recently initiated processes to evaluate and propose revisions to their approaches to the regulation of products of agricultural biotechnology.
On May 31, 2018, the FDA announced two new guidances designed to help generic drug manufacturers to obtain access to shared Risk Evaluation and Mitigation Systems programs, thereby promoting competition and access.
On July 6, 2018, the implementation day for the Section 301 “List 1” duties, the United States Trade Representative released the procedures for filing exclusion requests for List 1 products subject to the 25 percent tariff pursuant to Section 301 of the Trade Act of 1974.
The association between the alcohol beverage and cannabis industries continues to grow. Dan O'Neill, a former CEO of Molson Brewery and past senior executive at Campbell Soup Company and H.J. Heinz, has recently joined the board of CannaRoyalty.
The Fifth Circuit recently held that plaintiffs seeking benefits, under plans governed by the Employee Retirement Income Security Act of 1974 and non-ERISA plans, need not identify and include specific plan provisions in their complaints to survive motions to dismiss.
The US Department of Justice remained busy in its first year of the Trump Administration, charging 20 individuals with violations under the US Foreign Corrupt Practices Act — the second highest year of individual prosecutions since 1977.
In the wake of the “Me Too” movement and following a trend of recent legislation, on May 15, 2018, Maryland Governor Larry Hogan (R) approved the Disclosing Sexual Harassment in the Workplace Act of 2018. The Act becomes effective on October 1, 2018.
The US Court of Appeals for the Second Circuit just issued a 32-page decision affirming the district court’s conflict of laws ruling, in favor of an Arent Fox LLP client, that New York law, rather than New Jersey law, applied to an insurable interest dispute between AEI Life LLC and Lincoln Benefit
Medical devices containing animal derived ingredients that have been approved by the Food and Drug Administration now may enter the US without the need for an import permit from USDA’s Animal and Plant Health Inspection Service.
Despite Secretary Mnuchin’s statement last week that the Section 301 tariffs were “on hold,” President Trump announced this morning that he is moving ahead with the additional 25 percent ad valorem tariffs on certain Chinese imports to protect US intellectual property rights.
US Bankruptcy Judge in the US Bankruptcy Court for the Southern District of New York granted Avanti Communications Group PLC’s (“Avanti”) request to recognize the UK court-sanctioned scheme of arrangement and enforce the guarantee releases provided by Avanti’s affiliates on certain debt.
On May 20, 2018, Secretary of the Treasury Steven Mnuchin stated that the US was “putting the trade war on hold,” pending negotiations with China to reduce the US trade deficit and address certain acts, policies, and practices related to intellectual property rights.
At Arent Fox, opportunity is a function of creativity, drive, and talent. You won’t find a top-down management structure setting the tone at our firm. Because we’re not a corporation, we’re a partnership. You’re in the driver’s seat. Let’s go.